Aclaris Therapeutics IncEigentümerstruktur
| Preis (2026-07-28) | 52W Hoch | 52W Tief |
| 5.33 USD | 5,88 USD | 1,46 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 10 USD | 3 | 2 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 139.663.680 | 10,93 | 5,81 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Aclaris Therapeutics Inc
Mitarbeiter 69
Handelsplatz NASDAQ
Ticker Symbol ACRS
IPO Datum 2015-10-07
Adresse 701 Lee Road, Wayne, PA, United States, 19087
Webseite https://www.aclaristx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Neal S. Walker D.O., M.D. | Co-Founder, CEO & Chairman |
| 2 | Dr. Hugh M. Davis Ph.D. | President, COO & Director |
| 3 | Mr. Kevin Balthaser | Chief Financial Officer |
| 4 | Mr. James Loerop | Chief Business Officer |
| 5 | Dr. Roland Kolbeck Ph.D. | Chief Scientific Officer |
| 6 | Mr. William C. Roberts | Senior Vice President of Corporate Communications & Investor Relations |
| 7 | Mr. Matthew Rothman J.D. | General Counsel & Corporate Secretary |
| 8 | Mr. Steve Tucker | Executive Vice President of Project Leadership |
| 9 | Dr. Jesse W. Hall M.D. | Chief Medical Officer |
| 10 | Ms. Nina Samra M.S. | Senior Vice President of Clinical Operations |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BML Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 2 | Deep Track Capital, LP | 0,00% | 0,00 Mio. USD |
| 3 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 4 | RA Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 5 | Vivo Capital, LLC | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Frazier Life Sciences Management, L.P. | 0,00% | 0,00 Mio. USD |
| 9 | Rock Springs Capital Management LP | 0,00% | 0,00 Mio. USD |
| 10 | Decheng Capital LLC | 0,00% | 0,00 Mio. USD |
| 11 | Adage Capital Partners Gp LLC | 0,00% | 0,00 Mio. USD |
| 12 | Balyasny Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 13 | Kalehua Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 14 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 15 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 16 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 17 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 18 | BRAIDWELL LP | 0,00% | 0,00 Mio. USD |
| 19 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 20 | Palo Alto Investors, LLC | 0,00% | 0,00 Mio. USD |